2023 in Review: Nvidia, Interest Rates, Taylor Swift
Motley Fool Money
00:00
CRISPR Breakthroughs and Security Solutions
This chapter explores the advancements in gene editing technology by CRISPR Therapeutics, specifically in treating sickle cell anemia, while contemplating the speculative nature of such investments. The discussion shifts to identity security and market opportunities, providing insights into software solutions for business security alongside a lighter take on two-factor authentication challenges.
Play episode from 34:49
Transcript
